Raymond James began coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report sent to investors on Thursday morning, Marketbeat.com reports. The firm issued an outperform rating and a $208.00 target price on the biopharmaceutical company’s stock. ALNY has been the subject of a number of other research reports. HC Wainwright […]
Needham & Company LLC Reaffirms Buy Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Reaffirmed by Royal Bank of Canada theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $211.65, but opened at $200.00. Alnylam Pharmaceuticals shares last traded at $194.01, with a volume of 373,694 shares traded. Wall Street Analyst Weigh In A number of research firms have issued […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Stifel Nicolaus in a report released on Thursday, Benzinga reports. They presently have a $240.00 price target on the biopharmaceutical company’s stock. Stifel Nicolaus’ target price indicates a potential upside of 23.97% from the company’s previous close. […]